Correlation between severity of hepatic steatosis and markers of cardiometabolic health, and effect of lanifibranor therapy in patients with non-cirrhotic NASH
Journal of Hepatology（2023）
Key words
lanifibranor therapy,hepatic steatosis,cardiometabolic health,non-cirrhotic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined